Astrazeneca reported $7.64B in Cash and Equivalent for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
AstraZeneca AZN:LN 7636M 196M
Astrazeneca AZN:US $ 7636M 196M
Bristol Myers Squibb BMY:US $ 10982M 3564M
Canopy Growth Corp WEED:CN C$ 718.06M 383.76M
Catalent CTLT:US $ 988.1M 155M
Corcept Therapeutics CORT:US $ 52.38M 23.81M
Drreddys Laboratories RDY:US $ 504M 1598M
Eli Lilly And LLY:US $ 3002.4M 654.7M
Endo International Ordinary Shares ENDP:US $ 1427.78M 214.34M
Genmab GEN:DC DK 7892M 632M
GlaxoSmithKline GSK:LN 4757M 1535M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Horizon Pharma HZNP:US $ 811.61M 1268.3M
Lannett LCI:US $ 81.29M 47.07M
Novartis NOVN:VX SF 3801M 5857M
Pacira Pharmaceuticals PCRX:US $ 66.7M 33.26M
Perrigo Ordinary Shares PRGO:US $ 470.9M 170.6M
Phibro Animal Health PAHC:US $ 49.1M 14.57M
Prestige Brands PBH:US $ 32.3M 29.8M
Supernus Pharmaceuticals SUPN:US $ 255.64M 33M
Teva Pharmaceutical Industries TEVA:US $ 1743M 434M
Valeant Pharmaceuticals VRX:CN $ 679M 74M
Zoetis ZTS:US $ 3600M 2M